MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$207,898
Net Income
-$2,264,526
Net Profit Margin
-1089.25%
EPS
-$0.9
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Product revenues net of discounts and rebates
207,898
162,092
303,385
437,602
Cost of revenues
151,100
85,715
120,682
537,690
Gross profit
56,798
76,377
182,703
-100,088
Research revenues
0
0
12,994
90,960
Net revenue
56,798
76,377
195,697
-9,128
Research and development
598,653
281,464
638,873
809,777
General and administrative expenses
1,729,247
1,889,874
1,474,175
1,506,620
Total operating expenses
2,327,900
2,171,338
2,113,048
2,316,397
Loss from operations
-2,271,102
-2,094,961
-1,917,351
-2,325,525
Interest expense
1,403
1,389
3,086
1,708
Change in fair value of derivative liabilities
5,665
4,567
109,644
21,103
Other income, net
12,584
10,762
57,032
31,550
Total interest and other income (expense), net
-
-
476,480
-
Total interest and other income (loss), net
5,516
4,806
-
8,739
Loss from operations before provision for income taxes
-2,265,586
-2,090,155
-1,440,871
-2,316,786
Provision for income taxes (note 10)
0
0
-1,813
250
Net loss
-2,265,586
-2,090,155
-1,439,058
-2,317,036
Net loss noncontrolling interest
-1,060
-941
-499
-712
Net loss attributed to 60 degrees pharmaceuticals, inc
-2,264,526
-2,089,214
-1,438,559
-2,316,324
Basic EPS
-0.9
-1.28
-1.955
-0.66
Diluted EPS
-0.9
-1.28
-1.955
-0.66
Basic Average Shares
2,653,848
1,725,758
670,211*
3,675,407
Diluted Average Shares
2,653,848
1,725,758
670,211*
3,675,407
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss attributed
to 60 degrees...
-$2,264,526
(-30.62%↓ Y/Y)
Net loss
noncontrolling interest
-$1,060
(11.96%↑ Y/Y)
Net loss
-$2,265,586
(-30.59%↓ Y/Y)
Other income, net
$12,584
(-3.69%↓ Y/Y)
Product revenues net of
discounts and rebates
$207,898
(105.98%↑ Y/Y)
Loss from operations
before provision for...
-$2,265,586
(-30.70%↓ Y/Y)
Total interest and
other income (loss),...
$5,516
(104.29%↑ Y/Y)
Gross profit
$56,798
(11.63%↑ Y/Y)
Change in fair value of
derivative liabilities
$5,665
(-95.97%↓ Y/Y)
Interest expense
$1,403
(14.91%↑ Y/Y)
Cost of revenues
$151,100
(201.89%↑ Y/Y)
Loss from operations
-$2,271,102
(-41.52%↓ Y/Y)
Net revenue
$56,798
(-77.97%↓ Y/Y)
Total operating
expenses
$2,327,900
(24.98%↑ Y/Y)
General and
administrative expenses
$1,729,247
(7.22%↑ Y/Y)
Research and development
$598,653
(139.57%↑ Y/Y)
Buy us a coffee
60 DEGREES PHARMACEUTICALS, INC. (SXTP)
60 DEGREES PHARMACEUTICALS, INC. (SXTP)